𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Protective effect of RC-3095, an antagonist of the gastrin-releasing peptide receptor, in experimental arthritis

✍ Scribed by P. G. Oliveira; R. Grespan; L. G. Pinto; L. Meurer; J. C. T. Brenol; R. Roesler; G. Schwartsmann; F. Q. Cunha; R. M. Xavier


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
302 KB
Volume
63
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Effect of somatostatin analog RC-160 and
✍ Jacek Pinski; Andrew V. Schally; Gabor Halmos; Karoly Szepeshazi 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 679 KB

## Abstract Nude mice bearing xenografts of the androgen‐independent human prostate‐cancer cell line PC‐3 were treated for 4 weeks with somatostatin analog RC‐160, bombesin/gastrin‐releasing peptide (GRP) antagonist (RC‐3095), or the combination of both peptides. In the first experiment, treatment

Inhibition of growth of MKN45 human gast
✍ Jucek Pinski; Gabor Halmos; Tetsu Yano; Karoly Szepeshazi; Yunfeng Qin; Tibor Er 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 853 KB

## Abstract Nude mice bearing xenografts of the gastrin‐responsive human gastric carcinoma MKN45 cell line were treated for 4 to 5 weeks with bombesin/gastrin‐releasing‐peptide(GRP) antagonist (RC‐3095), somatostatin analogues RC‐160 and SMS 201‐995, or the combination of RC‐3095 and RC‐160. Tumor